AU Patent

AU2010207740B2 — Delayed-release glucocorticoid treatment of asthma

Assigned to Horizon Pharma Switzerland GmbH · Expires 2016-06-16 · 10y expired

What this patent protects

The present invention refers to the treatment of asthma by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.

USPTO Abstract

The present invention refers to the treatment of asthma by administering a delayed-release dosage form of a glucocorticoid to a subject in need thereof.

Drugs covered by this patent

Prograf (TACROLIMUS) · Astellas Pharma

Patent Metadata

Patent number: AU2010207740B2
Jurisdiction: AU
Classification: —
Expires: 2016-06-16
Drug substance claim: No
Drug product claim: No
Assignee: Horizon Pharma Switzerland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.